Shaolin Capital Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Shaolin Capital Management’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-121,714	Closed	-$1.25M	–	1044
2023 Q1	$1.25M	Sell	121,714 -125,000	-51%	-$1.27M	0.04%	281
2022 Q4	$2.48M	Buy	246,714 +25,000	+11%	+$249K	0.07%	279
2022 Q3	$2.18M	Hold	221,714	–	–	0.06%	349
2022 Q2	$2.16M	Sell	221,714 -200	-0.1%	-$1.95K	0.05%	392
2022 Q1	$2.16M	Sell	221,914 -300,538	-58%	-$2.92M	0.05%	395
2021 Q4	$5.05M	Buy	+522,452	New	+$5.13M	0.13%	207

Shaolin Capital Management's ORIA Position: Q2 2023 in Review

Shaolin Capital Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 121,714 shares — an estimated $1.25M sold.

Shaolin Capital Management first reported a position in ORIA in Q4 2021 and held it in 6 quarters. The position peaked at $5.05M in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

Shaolin Capital Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
Shaolin Capital Management sold 121,714 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.25M.
Shaolin Capital Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2021 and held it in 6 quarters.
Shaolin Capital Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $5.05M in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Shaolin Capital Management's 13F filing for Q2 2023, filed 15 Aug 2023.